Head and Neck Cancer Treatment: The Most Complex Plan on the Board

When a head and neck cancer case lands on CAMP dosimetrist Valerie James’s treatment planning screen, she doesn’t start with the tumor. She starts with everything around it. 

“There’s quite a bit of normal tissue structures we need to look at, and a lot of these structures are pretty sensitive to radiation,” says Valerie, a medical dosimetrist with CAMP. “So we really have to focus on those normal tissues a lot more here.” 

That focus complicates head-and-neck planning compared to almost every other site a dosimetrist will encounter in their career. It’s not just technically demanding, the margin for error is measured in millimeters, and the plan you build on day one may need to be rebuilt two or three more times before the patient finishes treatment. 

A Different Kind of Puzzle 

Compare a pelvic plan to a head and neck plan, and the difference is immediately visible. The structure list for a head and neck case is significantly longer. The dosimetrist is working around the spinal cord, brainstem, parotid glands, mandible, larynx, oral cavity, cochlea, thyroid, and pharyngeal constrictor muscles, among others, all packed into a relatively small treatment field. Many of those structures will overlap with the area being treated. 

“It’s kind of a puzzle,” Valerie says. “To start, we may crop out quite a few of our normal tissues just to be able to avoid as much as we can.” 

The goal is always to deliver enough dose to control the tumor while keeping radiation away from the structures that govern a patient’s quality of life. That includes their ability to produce saliva, swallow food, and avoid painful skin reactions. Protecting the person around the tumor is equally as important as controlling the tumor. 

The Parotid Problem 

The parotid glands sit at the center of one of the most consistent trade-offs in head and neck planning. These are the salivary glands responsible for most of the mouth’s moisture, and damage to them from radiation is often permanent. Overdose leads to xerostomia, dry mouth that can make eating, speaking, and sleeping difficult for the rest of a patient’s life. 

Valerie and her colleagues push hard to spare the parotids wherever possible, but the tumor doesn’t always cooperate. 

“That’s not always possible when the target is overlapping, which is pretty common,” she says. “There’s kind of a risk versus reward here.” 

When the parotid and the tumor share the same space, the conversation shifts to the physician. How much parotid dose is acceptable given where this tumor is? Can the contralateral side be spared even if the ipsilateral can’t? These are decisions made on a case-by-case basis, with ongoing back-and-forth between the dosimetrist and the oncologist. The plan is the product of that conversation, not just the software. 

What the Patient Goes Through 

For dosimetrists who are new to head and neck planning, it helps to understand what the patient is actually experiencing throughout treatment.  

It starts at simulation. Before treatment ever begins, a thermoplastic mask is heated and molded directly to the patient’s face. That mask gets bolted to the treatment table at every session to keep the patient’s head in exactly the same position, day after day. 

“Being locked into that mask every day for treatment isn’t so pleasant,” Valerie says. 

From there, the reactions the planning team is working to prevent become very real for the patient over the course of treatment. Skin reactions around the neck, dry mouth, and esophagitis aren’t edge cases. These are common, and how well the plan is built has a direct effect on the severity of potential side effects. 

Valerie recalls one case that stayed with her: a patient who had been using a lotion on their neck with an aluminum base. It caused a severe skin reaction. “It’s something pretty rare I’ve seen, but I think it’s something I always think about,” she says. “If we start seeing a skin reaction on a patient, that’s something to question up front.” It’s a reminder that what patients bring into treatment, not just the tumor, can change the picture. 

Plans That Change Mid-Treatment 

Head and neck is also the site where dosimetrists replan most often. That’s partly because patients lose weight during treatment, sometimes significantly, because eating becomes difficult. Weight loss changes the shape of the neck, which changes the geometry of the plan. 

Tumor shrinkage adds another variable. As the cancer responds to treatment, the target volume changes and the plan built around the original tumor may no longer be accurate. 

“Head and necks are probably the ones we replan the most,” Valerie says. “I’d say most head and necks are at least replanned once. And I’ve seen head and neck plans replanned up to four times over the course of an entire treatment.” 

Patients are imaged daily for set up and these images are reviewed by the physician in comparison with the original CT scan used for treatment planning, so there is regular opportunity to notice a change in anatomy. Additionally, medical physicists perform a weekly review of every patient on-treatment, which includes a review of the daily images for an extra set of eyes. If there is a notable change, a re-plan process is initiated and the team moves quickly. A new scan is often done the same day the change is identified. The goal is to have a new plan ready by the following day so treatment continues without interruption. That means the dosimetrist has to be efficient under a time constraint while building a plan that’s just as carefully considered as the original. 

What New Dosimetrists Miss 

Valerie is straightforward about the gap between a plan that looks good on paper and one that’s genuinely good for the patient. 

“You can get a very good plan. At least what looks good on paper. You’ll be meeting your constraints and you’ll have a lot of target coverage,” she says. “But I think a lot of times on these cases, things get overlooked that can make a pretty big difference in a patient’s comfort during treatment.” 

She points to low-dose sparing as the place where newer dosimetrists often leave something on the table, such as pushing dose off the skin at the front of the neck, breaking up the 50% dose in the space between nodal volumes and protecting the posterior skin, or even the area where the patient has hair, to reduce hair loss. None of these details show up as a constraint violation, but they matter to the patient. 

Communication Is Key 

Head and neck planning requires more ongoing communication with the physician than almost any other site. Constraints aren’t just set at the start and forgotten. They’re negotiated, revisited, and adjusted as the plan develops and as the patient anatomy changes throughout treatment. 

“Our job is very collaborative with the doctors, and this is probably the biggest thing you need to have open lines of communication for,” Valerie says. “It’s going to be a lot of back and forth.” 

For dosimetrists who are newer to this treatment site, that collaboration is part of what makes it challenging. Knowing when to push a plan further versus when to bring the physician into the conversation is a judgment skill that develops over time. It’s one of the things Valerie points to when thinking about what separates a competent head and neck planner from a great one. 

Adaptive planning technology has made some of this easier. The ability to replan more efficiently and account for anatomical changes during treatment has improved meaningfully in recent years, and Valerie sees that continuing. But the judgment at the center of the work, the decisions about trade-offs, timing, and what each patient specifically needs, that stays with the dosimetrist.